Books about Chemotherapeutics from Amazon.com

The text that sets the standard in Medical Pharmacology is now in full-color!

. .

Organized to reflect the syllabi in Pharmacology courses, Basic And Clinical Pharmacology covers all the essential concepts you need to know about the science of pharmacology and its application to clinical practice. It is acknowledged worldwide as the most current, authoritative, and comprehensive book for Medical Pharmacology and other health sciences and is without the doubt the most recognized text on the subject.

.
Price: $64.95 [Notify me when price goes down.]

Cancer chemotherapy can be traced back to the 1940 s and since then the world has witnessed the discovery and the important application of several new drugs. The successes of combination chemotherapy suggested that all cancers can be treated provided that the correct combination of drugs at the correct doses and correct intervals are established. However, with time, tumor cells develop mechanisms of resistance to apoptosis and no longer respond to the majority of cytotoxic therapies. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy, edited by Benjamin Bonavida, reviews novel approaches developed to reverse tumor cell resistance to chemo/immuno/radio-therapy and the use of various sensitizing agents in combination with various cytotoxics. Such sensitizing agents target gene products that regulate resistance and therefore identify novel targets for drug development. This book also introduces several of the current approaches that have been developed by established investigators in the field that are aimed at overcoming resistance. This book is the first that compiles studies on tumor cell sensitization and is useful for students, scientists, clinicians and pharmaceutical companies..
Price: $118.50 [Notify me when price goes down.]

An authoritative treatment of the discovery, development, and understanding of cancer chemotherapeutic agents. Addresses the major classes of chemotherapeutic agents, including antimetabolites, agents that react with DNA, inhibitors of transcription enzymes, topoisomerase inhibitors, DNA minor-groove binding compounds, antimotic agents, bleomycin group antitumor antibiotics, antihormones, paclitaxels, and photochemically activated agents. Provides an overview of the various classes of agents now considered important. Examines a method for determining the similarity of mechanism of the compounds in a given class..
Price: $19.93 [Notify me when price goes down.]

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on February 1, 2005. The length of the article is 1914 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Millennium announces promising findings from antibody-chemotherapeutic prostate cancer trial.
Publication:BIOTECH Patent News (Newsletter)
Date: February 1, 2005
Publisher: Biotech Patent News
Volume: 19 Issue: 2

Distributed by Thomson Gale.
Price: $5.95 [Notify me when price goes down.]

G. Landes). Baylor University, Dallas, TX. Intelligence Unit Series> Text on a new technology known as preactivation (a process of exposing photoactive compounds to light which converts them into new drugs). 1 foreign contributor. DNLM: Neoplasms-drug therapy. .
Price: $134.11 [Notify me when price goes down.]

2,5-dimethyl-celecoxib (DMC) is a close structural analog of the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib (Celebrex®) that lacks COX-2 inhibitory function yet maintains all of celecoxibs anti-tumor properties. We set out to investigate the potential of combining current glioblastoma chemotherapies with DMC as a new approach to enhance glioblastoma cell killing. DMC was not only able to enhance tumor cell killing when combined with other drugs but also induced glioblastoma growth arrest and apoptosis in low glucose and hypoxic conditions which are normally associated with chemoresistance. Therefore, if DMC were used in combination it may potentially be able to reverse this chemoresistance and restore or even enhance these drugs inhibitory effects. In addition, we also discovered inconsistencies between the MTT assay and other in vitro cell growth and survival assays. Hence, the MTT assay should be used with caution, and its results should be supported by other available in vitro assays..
Price: $60.63 [Notify me when price goes down.]